About Cleveland HeartLab
Cleveland HeartLab is a company based in Cleveland (United States) founded in 2008 was acquired by Quest Diagnostics in October 2017. Cleveland HeartLab has raised $38.85 million across 4 funding rounds from investors including Quest Diagnostics, Mutual Capital Partners and Excel Venture Management. Cleveland HeartLab operates in a competitive market with competitors including Conavi, Acarix, Ionetix, Infraredx and Kaminari Medical, among others.
- Headquarter Cleveland, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cleveland Heartlab, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$38.85 M (USD)
in 4 rounds
-
Latest Funding Round
$2.75 M (USD), Series B
Jul 08, 2014
-
Investors
Quest Diagnostics
& 6 more
-
Employee Count
Not available
-
Acquired by
Quest Diagnostics
(Oct 19, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Cleveland HeartLab
Unlock access to complete
Funding Insights of Cleveland HeartLab
Cleveland HeartLab has successfully raised a total of $38.85M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $2.75 million completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cleveland HeartLab
Cleveland HeartLab has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Quest Diagnostics, Mutual Capital Partners and Excel Venture Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early to late stage VC firm investing in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Cleveland HeartLab
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cleveland HeartLab
Investment portfolio details for Cleveland HeartLab
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cleveland HeartLab
Detailed financials for Cleveland HeartLab
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cleveland Heartlab Comparisons
Peer comparison for Cleveland HeartLab
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cleveland HeartLab
Cleveland HeartLab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conavi, Acarix, Ionetix, Infraredx and Kaminari Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Catheter-based ultrasound systems for cardiac imaging are developed.
|
|
| Locked | Locked | Locked |
A screening device for acoustic coronary artery diseases is provided.
|
|
| Locked | Locked | Locked |
Superconducting cyclotrons for PET radioisotopes are developed by Ionetix.
|
|
| Locked | Locked | Locked |
Coronary imaging and plaque detection system
|
|
| Locked | Locked | Locked |
Developer of diagnostic solution for vulnerable plaque in the coronary arteries
|
Detailed competitors of Cleveland HeartLab
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cleveland Heartlab
Complete news archive for Cleveland HeartLab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cleveland HeartLab
Cleveland HeartLab was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Cleveland HeartLab is headquartered in Cleveland, United States. It is registered at Cleveland, Ohio, United States.
Cleveland HeartLab is a funded company, having raised a total of $38.85M across 4 funding rounds to date.
Cleveland HeartLab is a specialty clinical laboratory and disease management company focused on biomarker technologies. Offers a group of biomarkers that provide insight into an individuals risk for cardiovascular diseases. Has developed a profile of tests focused on managing and reducing inflammation along with range of standard and advanced tests. Has one U.S. Food and Drug Administration-approved test that detects an enzyme called myeloperoxidase, or MPO, in the blood.CAP-accredited and CLIA-certified clinical reference laboratory. Covers North America and Europe.
Cleveland HeartLab has 7 investors. Key investors include Quest Diagnostics, Mutual Capital Partners, Excel Venture Management, Healthcare Ventures, and Second Generation Ltd.